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Summary 
In this study, core-shell structured nanofibers encapsulating model protein bovine 
serum albumin (BSA) and the growth factor human vascular endothelial growth factor 
(VEGF) were successfully fabricated by coaxial electrospinning. Two synthetic 
biodegradable polymers Poly(caprolactone) (PCL) and Poly(glycolic acid) (PGA) of 
different biodegradabilities were selected as the shell material for fabrication of 
BSA/PCL and BSA/PGA core-shell fibers, respectively. Graded flow rates were set for 
BSA when performing electrospinning, to obtain fibers encapsulating different amount of 
core component. 
The obtained core-shell nanofibers were evaluated as cell scaffolds with a function of 
biological agent delivery. The core-shell structure of the nanofibers was confirmed by 
transmission electron microscopy (TEM) and attenuated total reflectance Fourier 
transform infrared (ATR-FTIR) spectroscopy. When cultured with human dermal 
fibroblasts (HDFs), results from field emission scanning electron microscopy (SEM) and 
fluorescence-staining examination indicated favorable interactions between the core-shell 
nanofibers and cells. Release kinetic studies of both BSA/PCL and BSA/PGA core-shell 
fibers in the absence of HDFs showed a gradual release of BSA without burst release for 
more than thirty and ten days, respectively. However, faster release of BSA was observed 
when HDFs were cultured on both fibers.  
To investigate the biological activity protection of the core-shell fibrous scaffold, the 
growth factor VEGF, which specifically stimulates proliferation of human coronary 
artery endothelial cells (HCAECs), was encapsulated into PGA nanofibers. Proliferation 
                       
vi 
studies of HCAECs indicated that the VEGF released from the VEGF/PGA core-shell 
fibers retained its bioactivity of proliferation stimulation of HCAECs for at least 6 days.  
These results suggest that the core-shell structured nanofibers could possibly have 
good potentials as a novel controlled delivery system, as well as a tissue engineering 
scaffold encapsulating growth factors, enzymes, bioactive molecules, drugs, and even 
antibiotics for tissue repair and regeneration.   
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BSA   bovine serum albumin 
ECM   extracellular matrix 
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FITC-BSA  fluorescein isothiocyanate conjugated BSA 
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In the body, most of the cells are surrounded by a complex mixture of nonliving 
materials that makes up the extracellular matrix (ECM). This matrix is composed of 
various proteins and proteoglycans that are assembled into a highly ordered network of 
nanoscale fibers in close relation with the cells that secreted them. It also harbors various 
biologically active molecules such as growth factors, cytokines, enzymes and inhibitors. 
The composition and distribution of these molecules is not rigid, which gives rise to 
diversified organizations and functions of ECM in different tissues and at different 
development stages in the same tissue [1-3].  
Now it is clear that the ECM not only serves as a framework that anchors cells and 
provides sufficient mechanical strength to stabilize the tissue’s structure, it also plays an 
important role in regulating the behaviors of cells contacting it. The cell-ECM 
interactions contribute to cell migration, proliferation, differentiation, and programmed 
cell death, all of which are critical for tissue building, development, and function 
performance [4-8].         
Therefore, fabrication of tissue scaffold that can mimic the functions of natural ECM 
to support cells and present instructive signals to guide their behaviors is of great 
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importance for tissue engineering. Because of their similarity with the nanoscale fibrous 
structure of natural ECM, nanofibers have been broadly used as scaffolds in tissue 
engineering [9-12]. It has been reported that nanotopography influences cell behaviors 
ranging from cell adhesion, cell motility, surface antigen presence, cytoskeletal 
condensation, and gene expression [13-15]. Recently, electrospinning has attracted great 
attention as a straightforward method for the production of nano/microscale fibers owing 
to its simplicity, versatility, low cost, and scale-controllability. During electrospinning, 
the polymer jet is elongated and sprayed into fibers due to the presence of an electric field 
generated by high-voltage sources. These fibers are then collected onto a grounded 
surface [16].  
Many naturally derived and synthetic polymers have been used to produce 
nanofibrous scaffolds through electrospinning [17-21]. Naturally derived polymers, such 
as collagen, can provide innate binding sites for cells and promote cell adhesion and 
growth. However, these materials are usually isolated from animal or human tissues, thus 
they are normally not available in large amount and have batch-to-batch variations. On 
the contrary, synthetic polymers, such as poly(ε-caprolactone) (PCL), poly(lactic acid) 
(PLA), poly(lactic-co-glycolic acid) (PLGA), and poly(glycolic acid) (PGA), can be 
manufactured consistently on a large scale, and can also be processed into nanofibrous 
scaffold in a more controllable manner. The scaffold’s macro/micro structure, mechanical 
properties, and degradation time can be easily tailored and manipulated for different 
application purposes.  
A major drawback of synthetic polymer scaffolds is that they are not biologically 
active like the natural ECM: they could not present specific motifs on their surface for 
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specific cell targeting and binding, nor could they provide soluble factors or drugs for 
proper cell growth and development. To make up for these limitations, researchers have 
tried different approaches to incorporate bioactive molecules into the polymer scaffolds. 
RGD-containing sequences and many other cell adhesive peptides, saccharides, and 
proteins have been successfully embedded onto the nanofiber surfaces using adsorption 
or covalent grafting methods. Enhanced cell adhesion and improved cell functions have 
been observed through these treatments [22-24].  
However, fabrication of nanofibrous scaffolds complete with a function of 
biomolecule delivery that are capable of maximally preserving the bioactivity of these 
molecules and releasing them in a controllable manner is still a challenge. Mooney et al. 
used epidermal growth factor (EGF)-encapsulating microspheres combined with 
engineered polymeric scaffold for local release of EGF to transplanted hepatocytes [25]. 
Nonetheless the material preparation process is relatively complex and troublesome. 
Therefore, one-step fabrication of scaffold with innate controlled delivery system is 
preferred. To incorporate biomolecules into nanofibers, electrospinning of blends of 
growth factors [26], heparin [27], and DNA [28] with different carrying polymers have 
been developed. Yet, two obvious problems for this simple blend-electrospinning method 
are: 1) severe initial burst release phenomenon [26-28] which would be unavoidable 
because the biomolecules were mostly not encapsulated inside the nanofibers, and 2) as 
the bioactive molecules were simply mixed with carrier polymers during solution 
preparation and blend-electrospinning, this long time exposure to harsh organic solvent 
could possibly denature the bioactive molecules.  
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1.2 Motivations 
It has been proposed that the recently emerging coaxial electrospinning [12,29-33] 
could be a very promising technique to develop novel biomimetic nanofibrous scaffolds 
with a function of delivery. Unlike the blend electrospinning, soluble factors or drugs can 
be encapsulated into the polymer nanofibers in a form of a core-shell structure.  
In a coaxial electrospinning process, two polymer solutions can be concomitantly 
ejected out in an electrostatic field through two coaxial capillaries and result in a core-
shell structured nanofiber. Solutions that are not electrospinnable can still be electrospun 
into the core component as long as the shell fluid is electrospinnable [34]. The shell of 
the resultant nanofiber can provide considerable protections to the core component, and 
could also work as a shield to prevent initial burst release of the core.  
In the literature, it was noted that Jiang et al. [30], Huang et al. [29], and Zhang et al. 
[33] used coaxial electrospinning to produce protein- and/or drug- encapsulating core-
shell fibers and investigated their release behaviors. All these studies revealed a sustained 
release profile with no or alleviated initial burst release, as compared to the release 
profile of blended nanofibers [26-30,33]. But none of them studied the cells’ influences 
on the release behaviors of core-shell fibers, nor do they use such fibers as a cellular 
scaffold to investigate the cell-scaffold interactions. Zhang et al. [12] fabricated 
individually collagen-coated PCL nanofibers through coaxial electrospinning and 
demonstrated their great effect in promoting cell proliferation and migration. However, 
they didn’t introduce any soluble factor into this scaffold, thus no release study was done 
in this cell-scaffold system.  
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Moreover, although the coaxial electrospinning was proposed as a promising 
technique for fabrication of novel tissue scaffold with controlled release system, no study 
has been reported to our knowledge on verifying the biological activity protection of 
core-shell fibers to the encapsulated drugs/biomolecules. Therefore, primary studies on 
the biological activity protection of core-shell fibers were carried out in this work through 
cell-scaffold interaction investigations. Further research on this might be included in 
future work for proper understanding of the cell-scaffold interaction and the protection 
function of core-shell fibers. 
 
1.3 Thesis Overview and Scope 
The present study aims to fabricate novel tissue engineering scaffold with controlled 
delivery system, and also characterize its properties, release behaviors, as well as its 
bioactivity protection to the encapsulated component. Accordingly, the main objectives 
of this project are as follows: 
(1) Fabricate protein encapsulating nanofibrous scaffolds through coaxial 
electrospinning using two synthetic biodegradable polymers of different 
biodegradabilities, PCL and PGA; verify core-shell structure of the 
electrospun nanofibers and characterize the fabricated core-shell nanofibrous 
scaffolds; 
(2) Study the release profiles of the encapsulated protein from protein/PCL and 
protein/PGA core-shell fibers in the absence and presence of cell growth; 
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(3) Investigate the bioactivity of one growth factor VEGF after release from the 
core-shell fibrous scaffold through proliferation stimulation studies on 
HCAECs seeded on the scaffold.  
In Chapter 2, a detailed literature review will be presented, including introductions of 
tissue engineering, commonly used polymers for tissue engineering scaffolds, fabrication 
strategies for tissue engineering scaffolds, and dual functional scaffold with delivery 
system. The details of this research project are presented from Chapter 3. All the 
materials and methods employed in this project are described in Chapter 3. Fabrication 
and characterizations of the core-shell structured fibers via coaxial electrospinning are 
presented in Chapter 4. Two synthetic biodegradable polymers with different 
biodegradabilities, PCL and PGA, were used to fabricate core-shell nanofibers 
encapsulating one model protein BSA. Their core-shell structures were verified using 
TEM and ATR-FTIR analysis. The scaffolds were also characterized for their 
morphology, fiber diameter, and biocompatibility with cells. In Chapter 5, release 
profiles of the core-shell fibers in the absence and presence of cell growth have been 
studied. The biological activity protection of core-shell fibers to encapsulated core 
component is investigated in Chapter 6. The conclusions are presented in Chapter 7.   
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2.1 Tissue Engineering 
Tissue engineering was defined as “an interdisciplinary field that applies the 
principles of engineering and the life sciences toward the development of biological 
substitutes that restore, maintain, or improve tissue functions” [35]. As an 
interdisciplinary field, tissue engineering combines the knowledge from engineering 
areas such as material engineering, chemical engineering, and even computer engineering 
with the knowledge from biological areas such as cell biology, molecular biology, and 
anatomy. Tissue engineering is promising to solve the problem of donor organ shortage 
which is faced by lots of patients waiting for organ transplantation. The ideal tissue 
engineering approach is to isolate specific cells through a small biopsy from a patient, to 
grow them on a 3-D scaffold under precisely controlled culture conditions, to implant the 
construct to the diseased site in the patient’s body, and to direct new tissue formation into 
the scaffold that can be degraded over time [36,37], as illustrated in Fig. 2.1.  
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Each step indispensably guarantees the success of engineered new tissue, amongst 
which biodegradable scaffolds may be the core element. There are some general 
requirements for the materials used as tissue engineering scaffolds such as 
biocompatibility, biodegradation, and suitable mechanical properties. Detailed 
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Table 2.1 Requirements of tissue engineering scaffolds. 
Requirements Explanation 
Biocompatibility - non-toxic, non-carcinogenic, non-immunogenic, 
resistant to infection;  
- in application of blood contact, additional requirement 
including haemocompatible, lack of thrombogenicity, 
non-inflammatory 
Biodegradability - by-products of the biodegradation won’t cause any 
infection or inflammatory reaction;  
- by-products of the biodegradation should not be toxic, 
allergenic, thrombogenic nor carcinogenic;  
- appropriate degradation rate is required to be equal to 
that of regenerating tissue. 
Mechanical property - capable of supporting initial wound healing stress and 




Polymers (macromolecules) are the primary materials for various tissue engineering 
scaffolds such as skin, cartilage, and bone. Limited number of inorganic materials is used 
in bone and mineralized tissue engineering applications. In this chapter, the most 
commonly used polymers in tissue engineering are reviewed.  
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2.2 Commonly Used Polymers for Tissue Engineering Scaffolds  
Polymers used in tissue engineering can be naturally derived, synthetic or a 
combination of both. There are advantages and disadvantages for both synthetic and 
natural polymers when used as tissue engineering scaffolds which are summarized in 
Table 2.2.  
 
Table 2.2 Comparison between synthetic and natural polymers. 
Polymers Advantages Disadvantages 
Synthetic 
- easily synthesized with 
controlled molecular 
weight 
- other physical properties 
like mechanical 
properties 
- lack of intrinsic biological activity. 




- source-related variability and 
contamination; 
- limited control over parameters such 
as molecular weight; the potential for 
adverse immunological responses; 
- variation in degradation rates due to 
difference in host enzyme levels; 
- inferior mechanical properties. 
 
 
Biodegradable synthetic polymers including polyesters, poly(amides), 
poly(phosphoester), poly(phosphazenes), poly(orthoesters) and polyanhydrides have been 
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widely used in biomedical applications such as drug delivery and tissue engineering, 
amongst which polyesters are most commonly used in tissue engineering area. Here 3 
types of polyesters that are most frequently used in tissue engineering are discussed: 
Poly(glycolic acid), Poly(lactic acid), and Poly(ε-caprolactone) [38]. Structures and 
properties of these polyesters are summarized in Table 2.3. Copolymers of 
lactide/glycolide and lactide/caprolactone such as PLGA and PCL-PLLA are also 
extensively used in tissue engineering area.  
 
Table 2.3 Commonly used biodegradable synthetic polymers, polyesters, in tissue 
engineering. 




- Relatively hydrophilic; 
- semi-crystalline polymer; 
- degradable through hydrolysis at the 
ester bond in aqueous solution or in 




- More hydrophobic than PGA; 
- chirality; 





- degrade at a much slower rate than 
PGA and PLA 
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As the major requirement of tissue engineering scaffolds, those polyesters and their 
monomers should be biocompatible with human bodies. Polyesters degrade by hydrolysis 
of the ester bond. PGA is hydrophilic in nature and it degrades rapidly in vitro in aqueous 
solution or in vivo. PLA is more hydrophobic than PGA because of the extra methyl 
group in the repeating units, which leads to a slower hydrolysis. To get intermediate 
degradation rates between PGA and PLA, copolymers of PLGA are synthesized. In 
addition, PGA, PLA and PLGA are approved by US Food and Drug Administration 
(FDA) for some human clinical applications. PCL degrades at a significantly slower rate 
than PGA, PLA and PLGA which makes PCL a good candidate for long-term tissue 
engineering implants applications. Besides biocompatibility and biodegradation, these 
polymers should be fabricated into scaffolds with suitable mechanical properties in 
accordance with the implanted tissues. Mechanical properties of scaffolds fabricated by 
these polymers are decided mainly by the shape of scaffolds they are made into. The 
thermal and mechanical properties of polymers are summarized in Table 2.4.  
 














Yield    Break 
PGA 50,000 35 210 NA NA NA   NA 
L-PLA 50,000 54 170 28 1,200 7   6.0 
L-PLA 100,00- 58 159 50 2,700 2.6   3.3 
L-PLA 300,000 59 178 48 3,000 1.8   2.0 
DL-PLA 107,000 51 --- 29 1,900 4.0   5.0 
PCL 44,000 -62 57 16 400 7.0   80 
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Natural derived polymers are usually extracellular macromolecules. There are two 
main classes of natural polymers: (1) fibrous proteins such as collagen, elastin and 
fibronectin and (2) polysaccharides which are polymers of five-carbon (pentose) or six-
carbon (hexose) sugar molecules. Polysaccharides can be classified into several groups 
regarding the sources of polysaccharides. Glycosaminoglycans (GAGs) are unbranched 
polysaccharide chains composed of repeating disaccharide units, which are commonly 
found in extracellular matrix of mammalian. In invertebrates and plants, other types of 
polysaccharides are often found such as cellulose in higher plants, chitin/chitosan in 
arthropod exoskeletons, and alginate from marine brown algae. The most commonly used 
natural polymers including collagen, chitosan and GAGs will be discussed here. Their 
structures and properties are summarized in Table 2.5. 
To date, 27 types of collagen have been found, in which type I collagen is the most 
common type. As tissue engineering scaffolds, collagen has been utilized in the form of 
sponges, gels, woven and non-woven meshes, and decellularized tissue matrices. One 
concern with use of collagen is its mechanical properties. Collagen used as tissue 
engineering scaffolds are generally isolated by either enzymatic digestion or acid 
extraction from collagenous animal tissues, thus the original crosslinked triplehelix 
structure was destroyed. However, mechanical properties of collagen scaffolds can be 
strengthened by chemical crosslinking.  
Chitosan, similar to collagen, has been processed into porous structures for tissue 
engineering applications. The mechanical properties of chitosan scaffolds are mainly 
dependent on their pore size and pore orientation.  
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- triple helix structure;  
- each polypeptide chain has general sequence of 
Glycine-X-Y where X and Y are often proline 
and hydroproline; adhesive functions. 
Chitosan 
 
- deacetylated derivatives of chitin;  
- structure is similar to cellulose;  
- stable and crystalline;  
- normally insoluble in aqueous solutions above 
PH 7; 
- cationic ;  







- unbranched;  
- highly negatively charged;  
- there are four groups;  
- strongly hydrophilic;  
- usually  covalently linked to proteins in the form 
of proteoglycans which form hydrated gels to 
resist compressive forces in mammalian ECM. 
 
 
As natural ECM can be simply described as the protein network in association with 
GAGs hydrogels, GAGs are always used in combination with protein, growth factors to 
construct composite tissue engineering scaffolds. For example, crosslinked collagen-
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chondroitin sulfate complexes have demonstrated superior healing and regeneration in 
skin and nerve applications [40,41]. 
For tissue engineering applications, both synthetic and natural polymers need to be 
processed into scaffolds with suitable structure and chemical properties that match the 
reproduced tissue. The following section will introduce some commonly used methods 
for fabricating tissue engineering scaffolds.  
 
2.3 Fabrication Strategies for Tissue Engineering Scaffolds 
The natural extracellular matrix (ECM) plays an important role in the integrity of 
most tissues. It serves as a natural web of micro/nanofibers that anchors cells, provides 
sufficient mechanical strength to stabilize the tissue’s structure, and also takes part in 
regulating the behaviors of cells contacting it. Therefore, fabrication of scaffolds that can 
mimic the structure and functions of natural ECM is of great importance to tissue 
engineering. Different materials and fabrication techniques have been explored for this 
purpose: electrospinning, molecular self-assembly, fabrication methods for 3-D porous 
composite scaffolds, and hydrogels. We will introduce these techniques in more details in 
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2.3.1 Electrospinning 
Recently, electrospinning has attracted increasing attention as a simple method to 
generate nonwoven mats of nano/microscale fibers because of its simplicity, versatility, 
low cost, and scale-controllability. This process was first patented by Formhals in 1934 
[42] and until 1990s it has regained more attentions.  
 
          












Taylor cone Polymer jet 
Nonwoven nanofiber mat 
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Successful electrospinning requires the use of a high voltage supply, a capillary tube 
with a small-diameter needle, an appropriate polymer solution or melt system, and a 
metal collector (Fig. 2.2). In electrospinning, a strong electric field is generated between 
the capillary tip containing a polymer solution or melt and the metal collector. This 
induces charging of the polymer droplet at the capillary tip held by its surface tension. 
Mutual charge repulsion and the attraction between the charged droplet surface and the 
collector cause a force that acts against the surface tension [43]. At a critical voltage, this 
droplet is elongated to form a conical shape known as the Taylor cone [44]. When the 
applied voltage exceeds this critical voltage, the repulsion electrostatic force overcomes 
the surface tension and a stable jet could be ejected from the tip of the Taylor cone. The 
charged jet is accelerated towards the metal collector and undergoes bending instability, 
elongation, and solvent evaporation or jet solidification in the case of polymer melt 
during this period, which leads to rapid thinning of the jet and deposition of dry fibers in 
a random manner onto the collector [45]. Besides random nanofibers, uniaxially aligned 
nanofibers are also obtained successfully by electrospinning [46]. The electrospinning 
process can be adjusted to control fiber diameter and favor formation of uniform 
nanofibers without beads by varying solution concentration, strength of the electric filed, 
charge density of the solution, and solution feeding rate [47].  
 Many naturally derived and synthetic polymers have been used to produce 
nanofibrous scaffolds through electrospinning [17,19,20]. Naturally derived polymers, 
such as collagen, can provide innate binding site for cells and promote cell adhesion and 
growth. However, these materials are usually isolated from animal tissues, thus they are 
normally not available in large amount and have batch-to-batch variations. In contrast, 
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synthetic polymers, such as poly(ε-caprolactone) (PCL), poly(lactic acid) (PLA), 
poly(lactic-co-glycolic acid) (PLGA), and poly(glycolic acid) (PGA), can be 
manufactured reproductively on a large scale, and can also be processed into nanofibrous 
scaffold in a more controllable manner. The scaffold’s macro/micro structure, mechanical 
properties, and degradation rate can be easily tuned and manipulated for different 
applications.  
Nonetheless, a major drawback of synthetic polymer scaffolds is that they are not 
biologically active like the nature ECM: they do not present specific motifs on their 
surface for specific cell targeting and binding, nor do they provide soluble factors for 
proper cell growth and development. To overcome these limitations, researchers have 
tried different approaches to incorporate bioactive molecules into the polymer scaffolds. 
RGD-containing sequences and many other cell adhesive peptides, saccharides, and 
proteins have been successfully embedded onto the nanofiber surfaces using adsorption 
or covalent grafting methods to add biological cues to the scaffold’s surfaces. Enhanced 
cell adhesion and improved cell functions have been observed through these treatments 
[22-24]. To make scaffolds capable of releasing soluble factors, electrospun blended 
nanofibers were developed. Growth factors [26], heparin [27], and DNA [28] have been 
incorporated into nanofibrous scaffolds through this method for different applications. 
Sustained release was observed in these systems, but harsh initial burst release was 
inevitable. Moreover, in solution preparation and the following blending electrospinning 
process, bioactive molecules were mixed with carrier polymers in harsh organic solvent 
all the time, which could possibly cause denaturing of those bioactive molecules. Another 
newly emerged approach that can encapsulate soluble factors inside the polymer 
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nanofibers is coaxial electrospinning [29,30,33]. In this process, two components can be 
concomitantly ejected out through two coaxial channels to generate a core-shell 
structured nanofiber. Those bioactive soluble factors that are not electrospinnable can still 
be electrospun as the core component as long as the shell fluid is electrospinnable [34]. 
The core component can be protected inside the shell of the resultant fibers, which could 
also prevent the initial burst release of the core. Coaxial electrospinning has been used to 
produce protein- and/or drug-encapsulating core-shell fibers and their release profiles 
have been investigated [29,30,33]. All these studies revealed a sustained release profile 
with no or alleviated initial burst release, as compared to the release profile of blended 
nanofibers [26-30,33]. 
Electrospun nanofibers have been actively explored for applications in the area of 
tissue engineering because of the specific properties they have: easy to manufacture, 
scale-controllability, high porosity, high spatial interconnectivity, and potential of 
“biological” fine-tuning toward particular applications. Electrospun nanofibrous scaffolds 
have been attempted in engineering a number of tissues including epithelia [48], cartilage 
[49], bone [50], blood vessel [46], nerve [26], and heart [51]. Nanofibrous membranes 
also have great potentials in wound healing as a novel wound dressing material [11]. 
Further advances in the areas of fundamental matrix biology and electrospinning may 
enable the fabrication of more complex 3-D nanofiber matrices with molecular and 
structural information closer to the natural ECM. 
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2.3.2 Molecular Self-assembly 
Many natural biomolecules, like peptides and proteins, interact and self-assemble to 
form delicate structures that are associated with specific functions [52]. Ligaments and 
hair, for example, are assembled from collagen and keratin, respectively. DNA 
transcription is initiated by self-assembly of transcription factors, RNA polymerase, and 
DNA. Systematic studies and analysis of these natural existing self-assembly systems 
provide insight into the chemical and structural principles of peptide self-assembly, 
which inspires the development of molecular self-assembly as a new approach for 
fabrication of novel supramolecular architectures.  
By definition, molecular self-assembly is “the spontaneous organization of molecules 
under thermodynamic equilibrium conditions into structurally well-defined and rather 
stable arrangements through a number of noncovalent interactions” [53]. Therefore, 
design of finely tailored molecular building blocks that can assemble in multiple steps 
from bottom up through formations of numerous non-covalent bonds is the key principle 
for engineering molecular self-assembly. Typical non-covalent bonds include hydrogen 
bonds, ionic bonds, van der Waals’ bonds, electrostatic, and hydrophobic interactions 
[54]. These bonds are individually weak but once they are working together to hold the 
structure as a whole, they can control the structural conformation and form stable 
materials. So far, a number of molecular self-assembly systems have been designed and 
developed. These materials have considerable potentials in the area of tissue engineering 
as scaffolds, drug reservoir for delivery, or bioactive coatings (Fig. 2.3).  
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Figure 2.3 Fabrication of various peptide materials using self-assembly. (a) The ionic 
self-complementary peptide has 16 amino acids, ~5 nm in size, with an alternating polar 
and nonpolar pattern. (b) A type of surfactant-like peptide, ~2 nm in size, that has a 
distinct head charged group, either positively charged or negatively charged, and a 
nonpolar tail consisting of six hydrophobic amino acids. (c) Surface nanocoating peptide. 
(d) Molecular switch peptide, a type of peptide with strong dipoles that can undergo 




Many research groups have worked on the peptide and protein self-assembly systems. 
One example is the ionic self-complementary peptides or “molecular Lego”, which can 
form stable β-strand and β-sheet structures in aqueous solution with two distinct 
hydrophilic and hydrophobic surfaces [56]. These peptides are around 5 nm in size with 
alternating polar and nonpolar pattern. In aqueous solutions, the nonpolar residues shelter 
themselves from water while the charged residues form complementary ionic interactions 
with regular repeats on the hydrophilic surfaces [57]. The complementary ionic sides 
have been classified into different moduli i.e., modulus I, II, III, etc. and mixtures. This 
classification is based on the number of alternating positively charged and negatively 
charged amino acids on the hydrophilic surfaces of the molecules. For example, charge 
arrangement for modulus I is – + – + – + – +, for modulus II is – – + + – – + +, for 
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modulus III is – – – + + +. Different charge orientation can result in entirely different 
molecules. These well-defined sequences make highly ordered self-assembly become 
possible. Additionally, a broad range of peptides and proteins have been shown to self-
assemble into stable nanofiber structures (also called amyloid fibers) with similar scale to 
the extracellular matrices [58]. A number of mammalian cell types have been 
encapsulated or grown in this 3-D peptide scaffolds and promising results of cell 
attachment, proliferation, differentiation, migration, and ECM secretion were observed 
[57-59].  
Amphiphilic molecules have also been intensively studied as building blocks for self-
assembly [60-62]. A typical example of amphiphilic molecules from nature is 
phospholipids, which are molecules containing distinct hydrophobic and hydrophilic 
segments. Amphiphilic molecules readily partition in water and undergo self-assembly to 
form various structures including micelles, vesicles, and tubules. This is largely due to 
the hydrophobic forces that drive the hydrophobic region of each molecule away from 
water and towards each other. Nanotubules have been successfully fabricated from lipids 
[62], surfactant-like peptides [61], and polyglutamines [60]. Synthesis of self-assembly 
amphiphilic molecules that allow incorporation of specific biomolecular signals is also 
demonstrated [63], which underlines the potential of such molecular self-assembly 
system in incorporating both biomechanical and biomolecular cues.   
Molecular self-assembly can be used as coating to modify chemical and physical 
properties of other materials’ surface. Peptides that can interact with cells and adhere to 
other surfaces after self-assembly have been developed [64]. These peptides usually have 
three general regions: a ligand for specific cell recognition, an anchor for covalent 
Chapter 2 Literature Review                        
24 
bonding to the surface, and a linker in between [64]. Through this method, different 
complex cell patterns can be generated, which might provide a new way to study the cell-
cell interactions [55].  
 
2.3.3 Fabrication Methods of 3-D Porous Composite Scaffold  
There are mainly four fabrication techniques that can produce 3-D composite 
scaffolds with highly interconnected pores: thermally induced phase separation, solvent 
casting, rapid prototyping, and microsphere sintering (Fig. 2.4).  
 
 
Figure 2.4 Typical morphologies of porous polymer foams produced by different 
techniques and structure of cancellous bone. (a) thermal induced phase separation; (b) 
solvent casting and particle leaching; (c) solid freeform fabrication technique; (d) 
microsphere sintering [65]. 
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Thermally induced phase separation can generate 3-D polymer scaffolds with high 
porosity (~97%). Briefly, under certain conditions, a homogeneous polymer solution 
becomes thermodynamically unstable and tends to separate into two phases to lower the 
system’s free energy, a polymer-rich phase and a polymer-poor phase. After removing 
the solvent, the polymer-rich phase solidifies and forms a 3-D porous composite scaffold. 
The obtained scaffolds have highly interconnected pore structures and anisotropic tubular 
architectures. The pore morphology, mechanical properties, bioactivity and degradation 
rate of the scaffold can be controlled by varying the preparation conditions [66]. The 
primary disadvantages of thermally induced phase separation are time consuming, 
possibility of shrinkage, and small scale production [67]. Recently, 3-D polymer 
composite scaffolds containing TiO2 and Bioglass® have been synthesized by thermally 
induced phase separation and enhanced cell adhesion and function is demonstrated [68]. 
This method has been widely used to prepare scaffolds for various tissues, including 
nerve, muscle, tendon, ligament, intestine, bone, and teeth [66,67].  
In solvent casting, polymer is dissolved in an organic solvent, which is then cast into 
a pre-designed 3-D mold. Subsequently the solvent is removed [18,69]. Pre-synthesized 
microspheres, salt or sugar particles can be added to the polymer solution as porogens 
before casting and will be leached away after polymer solidification to generate 3-D 
scaffolds with more controlled porosity [70]. Main advantage of this method is easy to 
fabricate, while disadvantages include shape limitations, and possibility of toxic organic 
solvent remaining in the scaffolds which could cause denaturing of bioactive molecules 
incorporated in the scaffolds. Little work has been done to produce bioactive scaffolds 
using this method, probably due to its major drawback of low pore interconnectivity, 
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since many of the porogen might be still trapped in the polymer scaffold after leaching 
[65].     
Rapid prototyping is the method that allows precise control of 3-D pore architecture 
of the scaffolds with the help of computer. Scaffolds of complex shapes are accurately 
designed using digital data generated by an imaging source such as computer tomography 
[71]. Examples of rapid prototyping techniques include solid freeform fabrication [72], 
fused deposition modeling [73], and stereo lithography [74], all of which have been 
explored for scaffold fabrication. However, rapid prototyping technique has its inherent 
disadvantages such as limited material selection, increased scaffold fabrication time, 
inadequate resolution, and structural heterogeneity of the resultant scaffolds. 
In microsphere sintering, pre-synthesized polymer microspheres or 
polymer/ceramic/bioactive addiction composites are sintered to produce a 3-D porous 
scaffold [75]. Bioactive scaffolds can be fabricated through this technique, and they are 
demonstrated to be supportive to human osteoblast-like cells’ adhesion, growth, and 
mineralization [76]. Scaffolds fabricated through this technique can have graded porosity 
structures. Mechanical properties close to cancellous bone also become possible when the 
microspheres are sintered into cylindrical shapes [76]. However, production of 
interconnected pores in the scaffolds remains to be a challenge for microsphere sintering 
technique.   
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2.3.4 Hydrogels 
Hydrogels are crosslinked hydrophilic polymers whose molecular architecture has 
similar diffusive transportation, viscoelastic, and interstitial flow characteristics with 
natural ECM [77]. Examples of hydrogels are shown in Fig. 2.5. Hydrogels contain large 
amount of water without dissolution. The excellent physiochemical similarity of the 
hydrogels to the natural ECM makes them attractive candidates for certain tissue 
engineering applications and promising results have been presented [78]. Poly(ethylene 
glycol) (PEG) is the most frequently studied synthetic hydrogel and has been explored for 
potentials as scaffolds.  
 
 
Figure 2.5 Examples of different hydrogels. (a) Nanofibrillar hydrogels formed under 
physiological conditions from ionic self-assembling peptides (top); (b) Hybrid gels 
formed from cysteine-bearing cell-adhesive and proteolytically degradable peptide 
building blocks and vinylsulfone-functionalized PEG macromers; (c) Creation of 
synthetic ECMs from artificial protein polymers (aECM, represented here by one 
example of a broader family) containing bioactive domains derived from elastin and 
fibronectin (top). 
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However, lack of degradability is the major drawback of PEG hydrogel. To overcome 
this problem, enzymatic degradation sequences are introduced to the PEG backbone and 
copolymers are formulated from degradable polymers and PEG [79,80]. Other hydrogels 
attempted for applications in tissue engineering include semi-interpenetrating polymer 
networks [81], diblock copolypeptide amphiphiles containing polar and nonpolar 
segments [82], crosslinked alginates and polysaccharides [83], collagen [84], fibrin [85], 
and artificial proteins developed with recombinant DNA technology [86].  
 
2.4 Dual Functional Scaffold with Drug Delivery System 
An ideal drug delivery system should have the following properties: protection of the 
drug’s activity, controllable drug delivery rate, precise targeting to specific sites, 
prolonged duration of the drug’s therapeutic effects in the body, and also versatile 
applicability to a wide range of drugs. However, conventional drug delivery systems do 
not meet most of these requirements. The drugs’ physiochemical and biological 
properties often need to be modified when the drugs are applied with conventional 
delivery systems, which might lead to the weakening or even failure of the drugs’ 
pharmacological effects in the body. In many cases, conventional drug delivery systems 
do not provide controllable drug delivery rate or sustained release of the drugs. Sharp 
concentration increasing of the drugs is often seen after conventional drug 
administrations, and the peak value might even reach a potentially toxic level. Then the 
drug concentration would drop off in a relatively short period until next administration. 
As a result, patients are exposed to a highly fluctuating dosage of drugs, which would 
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seriously affect the drugs’ efficiency and safety. In addition, since most drugs are 
delivered throughout the body instead of specific areas where they are meant to have 
effects, side effects on other tissues will become unavoidable.  
Today, many new drug delivery systems have been developed and tested. Desired 
drug release can be achieved by nanoparticle- [87,88], hydrogel- [89,90], and nanofiber- 
[27-30] meditated deliveries. Moreover, drugs are primarily directed to their targeting 
sites, thus lower overall doses of drugs will be needed and exposure of other body tissues 
to the drugs will be reduced. This, in turn, would reduce undesirable side effects of the 
drugs. Among those, nanofibers are promising as a dual functional scaffold that not only 
provides controlled drug delivery but also supports cell and tissue growth. In the body, 
most tissues are surrounded by the natural scaffold, extracellular matrix (ECM), which 
supports cells and presents extrinsic signals to guide their behaviors [91,92]. Because of 
their similarity with the nanoscale fibrous structure of ECM, nanofibers have been 
broadly used as scaffolds for tissue engineering [9-12].  
Three major methods are used to incorporate drugs into electrospun nanofibers: (i) 
using polymer and drug mixed solution during electrospinning to produce blended 
nanofibers [27,28]; (ii) modifying nanofiber surface with drug after electrospinning 
[22,93]; (iii) encapsulating drug inside nanofiber through coaxial electrospinning to 
generate core-shell structured nanofibers [29-32]. The coaxial electrospinning method has 
many advantages over the other two, especially in the aspect that it can encapsulate drugs 
that are only water-soluble and will likely lose their bioactivity after dissolving in organic 
solvents. Recently, coaxial electrospinning has been explored for its potentials in release 
of bioactive molecules in the absence of cells [29,30] and surface functionalizing of 
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nanofibrous scaffolds for skin tissue engineering [12,29,30]. However, there are no 
reports of cells’ influence on the release of the drug encapsulated inside the fibers or the 
interactions between cells and such nanofiber scaffold. Additionally, to our knowledge, 
there has no study being reported on the biological activity protection of core-shell fibers 
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Chapter 3 
Materials and Methods 
 
3.1 Materials 
Poly(caprolactone) (PCL, Mw=80,000), bovine serum albumin (BSA), and 
fluorescein isothiocyanate conjugated BSA (FITC-BSA) were obtained from Sigma, 
USA. Poly(glycolic acid) (PGA, Mw>100,000) was purchased from Polysciences, USA. 
Human vascular endothelial growth factor (VEGF) was obtained from Pepro Tech, USA. 
The solvents 1,1,1,3,3,3-hexafluor-2-propanol (HFIP) (purity ≥ 99.0%) and phosphate-
buffered solution (PBS, pH 7.4) were purchased from Aldrich, USA. 2,2,2-
trifluoroethanol (TFE) (purity ≥ 99.0 %) was obtained from Fluka, Buchs, Switzerland. 
Human dermal fibroblasts (HDFs) were obtained from the National University Hospital, 
Singapore. Human coronary artery endothelial cells (HCAECs) were purchased from 
Cambrex, USA. Rhodamine-labeled phalloidin for F-actin was obtained from Sigma, 
USA. Mouse anti-human Platelet endothelial cell adhesion molecule-1 (PECAM-1 or 
CD31) was purchased from Cymbus, UK. Mouse anti-human Fibronectin (FN) was 
obtained from Medicorp, Canada. FITC-conjugated anti-mouse Ig antibody was 
purchased from Sigma, USA.    
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3.2 Fabrication of Core-shell Structured Nanofibers 
Core-shell structured nanofibers were prepared using coaxial electrospinning method 
as described previously [32,33]. Briefly, a spinneret consisting of two coaxial capillary 
tubes was used to electrospin two immiscible liquid solutions into a compound jet 
directly. After evaporation of the solvent during jet whipping-like movement [45,94,95], 
core-shell structured bi-component nanofibers were produced.  




Inlet of core 
component 
Inlet of shell 
component 
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    (B)      (C) 
Figure 3.1 Schematic illustration of the coaxial electrospinning setup (A) and the coaxial 
electrospinning device used in this study (B and C). 
 
 
tubes containing respective small-diameter needles were assembled together to form the 
compound spinneret. The diameters of the inner and outer capillary tube exits are 1.1 and 
2.5 mm, respectively. The inner tube is the feed channel for the core component and by 
connected to a high voltage power supplier, it is also used as the electrode for charging 
the spinning polymer solutions. The shell component is fed through the outer tube. 
Similar to conventional one-component electrospinning, at a critical voltage, the charged 
compound droplet at the end of the capillary tip is elongated to form a conical shape 
known as the Taylor cone [44]. When the applied voltage exceeds this critical voltage, 
the repulsion electrostatic force overcomes the surface tension and a stable compound jet 
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could be ejected from the tip of the compound Taylor cone. The charged compound jet is 
accelerated towards the metal collector and undergoes bending instability, elongation, 
and solvent evaporation during this period, which leads to rapid thinning of the 
compound jet and deposition of dry core-shell structured nanofibers in a random manner 
onto the collector[31,32,45]. This coaxial electrospinning process is believed to be fast 
enough to prevent any mixing of the core and shell components [31]. There are three 
special features of our coaxial electrospinning device: (1) separate controls of the feed 
rates of core and shell components; (2) adjustable protruding distance of the needle from 
inner capillary tube; (3) better coaxial alignment of the inner and outer capillary tubes. 
These features offer more adjustment dimensions for coaxial electrospinning and would 
facilitate fabrication as well as detailed investigation of core-shell structured nanofibers.  
For release study, BSA and FITC-BSA were used as the core component in non-
cellular and cellular modes, respectively. Slow degrading polymer PCL and fast 
degrading polymer PGA were used as the shell component for both modes. To prepare 
the core solutions, 0.1 M PBS (pH 7.4) was used as the solvent for both BSA and FITC-
BSA with final concentration of 0.1 g/ml and 0.01 g/ml, respectively. The shell solutions 
of PCL and PGA were made by dissolving PCL in TFE with final concentration of 0.12 
g/ml and dissolving PGA in HFIP with final concentration of 0.1 g/ml, respectively. 
When performing coaxial electrospinning, the flow rates of both shell components PCL 
and PGA were set at a constant of 2.0 ml/hr. In contrast, graded flow rates were set for 
the core component BSA and FITC-BSA at 0.06 ml/hr, 0.10 ml/hr, and 0.14 ml/hr, to 
obtain fibers encapsulating different amount of proteins.  
Chapter 3 Materials and Methods                        
35 
For the study of biological activity protection of core-shell fibrous scaffold, the 
growth factor VEGF was used as the core component while the shell component was 
PGA. The core solution was prepared by dissolving 10 µg VEGF in 1 ml PBS and 
subsequently stored in 4°C fridge until usage. The shell solution of PGA was prepared as 
described above. The electrospun VEGF/PGA core-shell fibers were kept in vacuum at    
-30°C until usage. 
During coaxial electrospinning, a high voltage from a high-voltage supply (RR50-
1.25R/230/DDPM, Gamma High Voltage Research, USA) was applied between the 
capillary tube exit and a grounded aluminum collector with a distance of about 12 cm for 
the fabrications of BSA/PCL (including both BSA/PCL and FITC-BSA/PCL), BSA/PGA 
(including both BSA/PGA and FITC-BSA/PGA), and VEGF/PGA core-shell structured 
nanofibers. Detailed parameters for coaxial electrospinning of BSA/PCL, BSA/PGA, and 
VEGF/PGA core-shell fibers will be discussed in Section 3.1 and 5.2.1. As controls, pure 
PCL and PGA nanofibers were also prepared with the conventional electrospinning [16].  
 
3.3 Core-shell Fiber Morphology Study 
Morphology of the electrospun protein loaded nanofibers was observed by a Quanta 
FEG 200 field emission scanning electron microscopy (SEM) (FEI Company, 
Netherlands) at an accelerating voltage of 10 kV. Before field emission SEM observation, 
samples were sputter coated with gold for 60 s using a JEOL JFC-1200 fine coater. Fiber 
diameters were analyzed by ImageJ software, based on the field emission SEM 
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microphotographs. For each of the three different nanofiber samples, more than 200 
individual fibers were analyzed.  
 
3.4 Verification of Core-shell Fibers 
The core-shell structure of the nanofibers was characterized by transmission electron 
microscopy (TEM) and attenuated total reflectance Fourier transform infrared (ATR-
FTIR) spectroscopy. For TEM observation, the protein-loaded nanofibers were prepared 
by directly depositing nanofibers onto copper grids pre-coated with a supportive Formvar 
film and carbon coating, and then drying in a vacuum oven for 48 hours. TEM images 
were obtained with a JEOL JEM-2010F FasTEM field emission electron microscopy 
(JEOL, Japan) operated at 100 kV. Based on the TEM microphotographs, fiber diameters 
and the corresponding wall thickness were analyzed.   
Surface composition of the protein-loaded nanofibers was analyzed using AVATAR 
300 ATR-FTIR spectroscopy (Thermo Nicolet, USA). ATR-FTIR spectra of core-shell 
structured nanofibers, pure PCL nanofibers, pure PGA nanofibers, as well as finely 
powdered BSA were generated using Nicolet OMNI-Sampler ATR Smart Accessory 
(Thermo Nicolet, USA). A background spectrum in air was taken for each sample 
spectrum. All spectra were collected at the resolution of 4 cm−1. Each spectrum 
represents an average of 128 individual scans. 
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3.5 Culture of HDFs and HCAECs 
Human dermal fibroblasts (HDFs) was cultured in high-glucose (25 mM) Dulbecco’s 
modified Eagle medium (DMEM) (Sigma, USA) supplemented with 10% fetal bovine 
serum and 1% penicillin-streptomycin at 37°C in 5% CO2 and subcultured 1:4 once every 
week. Before cell seeding, the nanofibrous scaffolds were glued on coverslips (Assistent, 
Germany) of 15-mm diameter with medical grade silicon adhesive (Rhodia Silicones, CA, 
USA) at room temperature for 6 hours and then transferred into 24-well culture plates 
(TPP, Switzerland). The scaffolds were sterilized with 70% ethanol for 30 minutes and 
washed with sterilized PBS solution three times. HDFs from a confluent flask were 
trypsinized, washed, and resuspended in medium. Cells were seeded at a density of 1×104 
cells/cm2 onto the surface of the scaffolds. Growth medium was exchanged timely. Cells 
from passage 11 to 13 were used for this study. 
Human coronary artery endothelial cells (HCAECs) were grown in endothelial cell 
basal medium supplemented with endothelial cell (EC) growth supplements (vascular 
endothelial growth factor (VEGF), human epidermal growth factor (hEGF), human 
fibroblast growth factor-B (hFGF-B), insulin-like growth factor type I (IGF-I), 
hydrocortisone, and ascorbic acid), 5% fetal bovine serum, and 1% penicillin-
streptomycin in a humidified incubator at 37°C in 5% CO2. The medium was replaced 
every 3 days and the cells were subcultured 1:3 once every week. Similarly, the 
nanofibrous scaffolds were glued on coverslips, and subsequently sterilized and washed 
before seeded with cells. Cells from passage 5 to 7 were used for this study. 
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3.6 Cell Morphology Study 
For SEM study, the scaffold samples were rinsed with PBS once, then fixed with 2% 
glutaraldehyde (Sigma, USA) for 1.5 hours and post-fixed with 1% OsO4 (Sigma, USA) 
for 20 minutes. The samples were dehydrated through a series of graded ethanol 
solutions: 50% ethanol for 15 minutes, 75% ethanol for 15 minutes, 95% ethanol for 15 
minutes twice, and 100% ethanol for 30 minutes twice. Subsequently the samples were 
treated with hexamethyldisilazane (HMDS) (Fluka, USA) for 15 minutes twice and air-
dried in a fume hood overnight. Dried samples were sputter coated with gold for 60 s 
using a JEOL JFC-1200 fine coater and observed under the field emission SEM at an 
accelerating voltage of 10 kV.  
 
3.7 Functional Marker Expression Study 
For HDFs grown on the FITC-BSA/PCL core-shell fibrous scaffold, their F-actin 
expression was studied. The cell-seeded scaffold samples were rinsed with PBS once, 
followed by fixation with 4% paraformaldehyde for 20 min and permeabilization with 
1% Triton-X for 10 minutes at room temperature. Then the samples were post-fixed with 
acetone:methanol (mixed in a 1:1 ratio) at -20 °C for 10 minutes. After blocking with 1% 
bovine serum albumin, the samples were incubated with rhodamine-labeled phalloidin 
(1:50 dilution in blocking solution) for 1 hour at room temperature. Then the samples 
were washed three times with blocking solution. Samples were permanently mounted 
with Vectashield Hard Set mounting media (Vector Laboratories, USA) which also 
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contains DAPI for nucleus staining. Confocal images were taken with an Olympus 
FV500 microscopy using Fluoview 4.3 software. All the confocal micrographs of the 
three different core-shell structured nanofibers were taken under exactly the same 
parameters. Pure PCL fibers under the same conditions were used as the control.  
HCAECs were examined for their CD31 and FN expressions. Cells were fixed with 
4% (w/v) paraformaldehyde in PBS at room temperature for 20 min, and washed with 
PBS three times. After blocking with 1% bovine serum albumin in PBS, the cells were 
incubated with the appropriate primary antibodies for 2 hours at room temperature in 
blocking solution. Then the cells were washed three times with blocking solution, and 
incubated with secondary antibodies for 1 hour in blocking solution at room temperature, 
followed by another three-time washing with blocking solution. Cells were permanently 
mounted with FluorSave Reagent mounting media (Calbiochem, USA). Primary 
antibodies were used at the following dilutions: anti-CD31 (1:10), and anti-FN (1:50). 
FITC-conjugated anti-mouse Ig antibody was used at 1:50. Nuclei were stained with PI (5 
µg/ml) for 1 min. Confocal images were taken with a Carl Zeiss confocal microscopy 
(LSM 510).                   
             
3.8 In vitro Release Study 
For the release study without cells, a known weight of BSA/PCL or BSA/PGA core-
shell structured nanofibers was suspended in 10 ml of PBS and subsequently incubated in 
a shaking water bath at 37°C. At predetermined time intervals, all 10 ml of BSA released 
in the PBS was removed and replaced with equal amount of fresh PBS. The BSA released 
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in the PBS was analyzed by a UV-spectrometer at the wavelength of 280 nm. The amount 
of BSA released was determined from a calibration curve. Pure PCL and PGA fibers 
under the same conditions were used as the control.   
Similar treatment was performed with the FITC-BSA/PCL and FITC-BSA/PGA core-
shell structured nanofibers for release study with cells. After careful pre-treatments 
(described in Section 3.5), fibers were seeded with HDFs and immersed in growth 
medium which was exchanged timely and analyzed for FITC-BSA concentration with a 
FLUOstar OPTIMA microplate reader (BMG Labtech, Germany; 485nm excitation, 
520nm emission). Pure PCL and PGA fibers were also used as the control under the same 
conditions. Total amount of the protein (BSA or FITC-BSA) encapsulated in nanofibers 
( totalM ) was determined by the following equation: 
( ) ( )
( ) ( )
( )
( ) ( ) 
i BSA total
o shell polymer fibers total
R ml hr C mg ml M mg
R ml hr C mg ml M mg M mg





i BSA o shell polymer
R C M
M
R C R C
× ×= × + ×      (2) 
where iR  and oR  were the inside and outside feed rate (ml/hr), respectively. BSAC  and 
 shell polymerC  were the BSA and shell component (PCL or PGA) concentration (mg/ml), 
respectively. fibersM  was the weight of the fibers (mg).     
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The cumulative amount of the protein released from the nanofibers was defined by 











               (3) 
in which Mt was the amount of protein released at time t, and Mtotal was the total amount 
of protein encapsulated in the fibers as defined above.   
 
3.9 Proliferation Stimulation Study 
Confluent HCAECs were trypsinized, washed, and resuspended in complete EC 
growth medium (described in Section 3.5). Afterwards, cells were seeded at 1.26×104 
cells/cm2 onto the surfaces of different substrates in starvation medium (EC basal 
medium without any growth factor, 1% fetal bovine serum, and antibiotics). After 2, 4, 
and 6 days, cells were fixed and treated for SEM imaging to determine corresponding cell 
number. Cells from passage 5 to 7 were used for this study.  
SEM images with magnification of 200x were used for cell counting. On each sample, 
5 symmetric locations ( jL , j=1, 2, 3, 4, 5) were selected and within each location, SEM 
images were taken at 3 randomly selected places ( iP , i=1, 2, 3), as shown in Fig. 3.2. Cell 
number was counted based on the SEM image of each place, and divided by the image 
area to get the cell density of that place, iPD (i=1, 2, 3). Therefore, the averaged cell 
density of each location would be  






3j i jL Pi
D D
=
= ∑ (j=1, 2, 3, 4, 5)                                            (4)  
The cell density of the whole sample is given by 
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5 5 3 5 3
1 1 1 1 1
1 1 1 1
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Figure 3.2 Schematic diagram of cell counting using SEM images. Big black boxes 
represent the symmetric 5 locations selected on each sample. Small white boxes represent 
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Chapter 4 
Fabrication of Core-shell Fibers and Characterizations 
 
4.1 Optimizations of Coaxial Electrospinning Parameters 
 
4.1.1 Coaxial Electrospinning of BSA/PCL Core-shell Fibers 
The processing parameters used to fabricate BSA/PCL (including both BSA/PCL and 
FITC-BSA/PCL) core-shell fibers with our coaxial electrospinning setup were listed in 
Table 4.1. In coaxial electrospinning, bioactive soluble molecules that are not 
electrospinnable can still be electrospun as the core component as long as the shell fluid 
is electrospinnable [34]. Thus the optimized electrospinning conditions for the shell 
component need to be determined before it is used for coaxial electrospinning. It was 
found that when the concentration of PCL in TFE was 12% (w/v) and feed rate was set at 
2 ml/hr, stable and continuous production of uniform PCL nanofibers without beads 
could be easily achieved in relatively broad ranges of voltage (>10 kV) and distance 
(>10cm). Therefore, 12% (w/v) PCL in TFE was used as the shell component for 
fabrication of all BSA/PCL core-shell fibers and its feed rate was set at a constant of 2 
ml/hr, as shown in Table 4.1.  
Since the inner core components used in this study were all proteins in PBS solution, 
which were not electrospinnable, their concentration changes had few influences on the 
coaxial electrospinning process. 10% (w/v) BSA in PBS and 1% (w/v) FITC-BSA in PBS 
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were used as the core component for the fabrication of BSA/PCL and FITC-BSA/PCL 
core-shell fibers, respectively (Table 4.1). The decrease of FITC-BSA concentration was 
due to the concern of high sensitivity of microplate reader used to measure the FITC-
BSA release from FITC-BSA/PCL core-shell fibers cultured with cells (described in 
Section 3.8). High concentration of FITC-BSA solution for coaxial electrospinning would 
lead to high loading amount of the protein into the core-shell fibers, which may result in 
overly high release and exceed the upper limit of the microplate reader’s measurement 
range.  
 
Table 4.1 Coaxial electrospinning parameters for BSA/PCL (including BSA/PCL and 























0.10 BSA/PCL 0.1 0.12 11.5 
0.14 
2 20.4 23 77 
0.06 
0.10 FITC-BSA/PCL 0.01 0.12 14 
0.14 
2 22 25 55 
 
 
The key issues in coaxial electrospinning are to control the shell thickness and to 
direct the amount of core component encapsulated inside the fibers. For this purpose, 
influences of different inner feed rates on the resultant fiber shell size and protein 
loadings were investigated. Graded flow rates were set for the core component BSA and 
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FITC-BSA at 0.06 ml/hr, 0.10 ml/hr, and 0.14 ml/hr, while the flow rate of shell 
component PCL was set at a constant of 2.0 ml/hr, to obtain fibers encapsulating different 
amount of proteins. This great difference between the inner and outer feed rates was 
necessary for stable jet formation and continuous core-shell fiber production, since BSA 
and FITC-BSA solution could not form fibers via electrospinning and they need the 
“guidance” of shell component as a template to form cable-type structures.  
When the inner feed rate was set higher than 0.14 ml/hr, fibers could not form 
however high the applied field intensity (voltage/distance) was. Therefore, 0.14 ml/hr 
was set as the highest inner feed rate investigated in this study. Another two inner feed 
rates decreasing by equal differences, 0.10 ml/hr and 0.06 ml/hr, were also selected for 
study. The protruding distance of the inner capillary tube below the outer capillary tube 
(Fig. 3.1) was also important for stable compound jet formation. It was carefully adjusted 
until a stable compound jet could be observed at the exit the capillary tube. Zussman et al. 
found that the optimal protrusion distance relies on several factors: the viscosity ratio of 
the core and shell liquids, the interfacial tension, and the feed rates of the inner and outer 
liquids [96].  
Voltage and distance were also adjusted accordingly when the inner feed rate was 
changed, to obtain suitable field intensity for stable and continuous core-shell fiber 
production. In most of the cases, same voltage and distance parameters for 0.14 ml/hr 
could also be applied to another two lower inner feed rates, 0.10 ml/hr and 0.06 ml/hr. 
Moreover, a significant increase of the applied voltage was observed for core-shell fiber 
fabrication (~ 20 kV) than that for the shell PCL fabrication alone (~ 12 kV), with all the 
other parameters remaining the same. This phenomenon could be attributed to the 
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“dilution” effect by the core BSA solution. During coaxial electrospinning, the compound 
fluid jet with PCL solution as the shell and BSA solution as the core was “diluted” by the 
low viscosity solution of BSA, as compared to the pure PCL fluid jet. Thus a higher 
voltage was necessary for the stabilization of compound jet and formation of core-shell 
fibers [29].      
          
4.1.2 Coaxial Electrospinning of BSA/PGA Core-shell Fibers 
The processing parameters used to fabricate BSA/PGA (including both BSA/PGA and 
FITC-BSA/PGA) core-shell fibers with our coaxial electrospinning setup were listed in 
Table 4.2. Similarly, the optimized electrospinning conditions for PGA were also studied 
before it is used for coaxial electrospinning. When the concentration of PGA in HFIP was 
10% (w/v) and the feed rate was set at 2 ml/hr,  stable and continuous production of 
uniform PGA nanofibers without beads could be easily fabricated in relatively broad 
ranges of voltage (>8.8 kV) and distance (>10cm). Therefore, 10% (w/v) PGA in HFIP 
was employed as the shell component for fabrication of all BSA/PGA core-shell fibers 
and its feed rate was set at a constant of 2 ml/hr as shown in Table 4.2.  
10% (w/v) BSA and 1% (w/v) FITC-BSA in PBS were still used as the core 
components here (Table 4.2).   
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0.10 FITC-BSA/PGA 0.01 0.1 11.5 
0.14 
2 16.3 20 61 
 
 
Similar to the BSA/PCL core-shell fiber fabrication, graded flow rates were also set 
for the core component BSA and FITC-BSA at 0.06 ml/hr, 0.10 ml/hr, and 0.14 ml/hr, 
while the flow rate of shell component PGA was set at a constant of 2.0 ml/hr. Voltage 
and distance were adjusted accordingly when the inner feed rate was changed, to obtain 
suitable field intensity for stable and continuous core-shell fiber production. As indicated 
above, same voltage and distance parameters for 0.14 ml/hr sometimes could also be 
applied to another two lower inner feed rates, 0.10 ml/hr and 0.06 ml/hr. And also a 
significant increase of the applied voltage was observed for core-shell fiber fabrication (~ 
10-16 kV) than that for the shell PGA fabrication alone (~ 8 kV), with all the other 
parameters remaining the same. This is likely due to the “dilution” effect by the core 
BSA or FITC-BSA solution as explained above.  
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4.2 Morphology of the Coaxially Electrospun Core-shell Fibers 
 
4.2.1 Morphology Observation by SEM 
In our previous study, it has been found that non-electrospinnable component such as 
BSA would compromise the fiber morphology if it was blended and electrospun together 
with an electrospinnable polymer [33]. However, if they are compounded into core-shell 
formed nanofibers with the non-electrospinnable component encapsulated by the 
electrospinnable polymer shell, the nanofibrous morphology remains. Results in current 
study were consistent with the earlier findings. Uniform ultrafine fibers were successfully 
fabricated under stable processing conditions, i.e., no dripping of droplets, formation of a 
stable compound Taylor cone at the exit of the capillary tube, and continuous jet ejection 
during coaxial electrospinning. As can be seen in the SEM images (Fig. 4.1 and Fig. 
4.2), randomly oriented, bead-free, and highly porous nanofiber mats were produced with 
all three inner feed rates. Although the core component BSA solution was not 
electrospinnable, it had little influence on the formation of resultant core-shell fibers.  
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Figure 4.1 SEM images of BSA/PCL core-shell structured nanofibers. The inner flow 
rates were set at 0.06 ml/hr (A), 0.10 ml/hr (B), and 0.14 ml/hr (C) when performing 
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Figure 4.2 SEM images of BSA/PGA core-shell structured nanofibers. The inner flow 
rates were set at 0.06 ml/hr (A), 0.10 ml/hr (B), and 0.14 ml/hr (C) when performing 
electrospinning, respectively. (A-C) Mag. 10000x. 
 
 
4.2.2 Fiber Diameter Distributions 
The size distribution results of both BSA/PCL and BSA/PGA core-shell fibers indicate 
that increase of the inner feed rate gave rise to increased fiber diameter. For BSA/PCL 
core-shell fibers, the increase of inner feed rate from 0.06 ml/hr, 0.10 ml/hr, to 0.14 ml/hr 
led to increased fiber diameter from an average of 169±61 nm, 215±61 nm, to 273±70 
nm, respectively (Fig. 4.3 and Table 4.3). These statistics were based on the 
A B 
C 
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Figure 4.3 Size distribution of the BSA/PCL core-shell structured nanofibers. The inner 
feed rates were set at 0.06 ml/hr, 0.10 ml/hr, and 0.14 ml/hr when performing coaxial 
electrospinning. These statistics were based on the measurements of more than 200 
individual fibers for each of the three different nanofiber samples. 
 
 
Similar trends were also observed in BSA/PGA core-shell fibers. Fibers with inner 
flow rate at 0.06 ml/hr, 0.10 ml/hr, and 0.14 ml/hr had an averaged fiber diameter of 
286±102 nm, 343±108 nm, and 444±145 nm, respectively (Fig. 4.4 and Table 4.3). 
These statistics were also based on the measurements of more than 200 individual fibers 
for each of the three different nanofiber samples. 



















































Figure 4.4 Size distribution of the BSA/PGA core-shell structured nanofibers. The inner 
feed rates were set at 0.06 ml/hr, 0.10 ml/hr, and 0.14 ml/hr when performing coaxial 
electrospinning. These statistics were based on the measurements of more than 200 




Table 4.3 Averaged fiber diameters of BSA/PCL and BSA/PGA core-shell fibers 
electrospun at 3 different inner feed rates when performing coaxial electrospinning. 
Averaged Fiber Diameters 
Inner Feed Rates 
Core-shell Fibers 
0.06 ml/hr 0.10 ml/hr 0.14 ml/hr 
BSA/PCL 169±61 nm 215±61 nm 273±70 nm 
BSA/PGA 286±102 nm 343±108 nm 444±145 nm 
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This positive correlation between inner flow rate and fiber diameter could be 
attributed to the die swell effect of viscoelastic polymers during extrusion process [33,96]. 
Upon exiting the inner capillary tube, the inner core liquid experienced a sudden increase 
in its diameter (Fig. 3.1). This is usually dependent on factors like concentration, 
spinneret length, extrusion rate, addition of stiffer fillers, and temperature. The swell 
effect of the core fluid would be simultaneously transferred to the shell fluid by 
expansion of the shell to a certain extent. Consequently the stretching ability of the 
compound jet during its instability development would be affected. As is well known, the 
bending instability during electrospinning is responsible for the formation of nano-/sub-
microscale ultrafine fibers [45,94]. It was also observed that if the inner fluid was not 
viscoelastic polymer, the swell effect would not be present. Song et al. fabricated iron-
platinum (FePt) nanoparticle/PCL core-shell fibers and they found that alternation of the 
inner feed rate of FePt nanoparticle solution did not affect the resultant core-shell fiber 
diameters [97,98].       
 
4.3 Verification of Core-shell Structure 
 
4.3.1 TEM Observation 
The core-shell structure of the nanofibers was examined by transmission electron 
microscopy (TEM) and attenuated total reflectance Fourier transform infrared (ATR-
FTIR) spectroscopy. Representative TEM images of BSA/PCL and BSA/PGA core-shell 
fibers are shown in Fig. 4.5 and Fig. 4.6, respectively. Sharp boundaries of core (FITC-
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BSA or BSA) and shell (PCL or PGA) components could be clearly observed. Moreover, 
for both BSA/PCL and BSA/PGA core-shell fibers, increased inner feed rate was found to 
lead to increased fiber wall thickness, as shown in Table 4.4. For BSA/PCL core-shell 
fibers with inside feed rates of 0.06 ml/hr, 0.10 ml/hr, and 0.14 ml/hr, the wall thickness 
to diameter ratio was found to be 0.2271 (SD=0.056), 0.2938 (SD=0.057), and 0.3537 
(SD=0.031), respectively. Similarly, the wall thickness to diameter ratio of BSA/PGA 
core-shell fibers was also increased with the inner feed rate, with 0.2045 (SD=0.026) at 
0.06 ml/hr, 0.2487 (SD=0.022) at 0.10 ml/hr, and 0.2803 (SD=0.023) at 0.14 ml/hr.    
 
                  
 
               
Figure 4.5 Representative TEM images of BSA/PCL core-shell structured nanofibers. The 
inner feed rates were set at 0.06 ml/hr (A), 0.10 ml/hr (B), and 0.14 ml/hr (C) when 
performing coaxial electrospinning, respectively. Mag. 15000x. 
A B 
C 
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Figure 4.6 Representative TEM images of BSA/PGA core-shell structured nanofibers. The 
inner feed rates were set at 0.06 ml/hr (A), 0.10 ml/hr (B), and 0.14 ml/hr (C) when 
performing coaxial electrospinning, respectively. Mag. 10000x. 
 
 
Table 4.4 Averaged wall thickness to fiber diameter ratio of BSA/PCL and BSA/PGA 
core-shell fibers electrospun at 3 different inner feed rates when performing coaxial 
electrospinning. These statistics were based on the measurements of more than 10 
individual fibers for each sample. 
Averaged Wall Thickness to Fiber Diameter Ratio 
Inner Feed Rates 
Core-shell Fibers 
0.06 ml/hr 0.10 ml/hr 0.14 ml/hr 
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4.3.2 ATR-FTIR Analysis 
To further confirm that BSA or FITC-BSA was encapsulated inside the fibers instead 
of being present on the surface, ATR-FTIR analysis was conducted to investigate the 
surface composition of the core-shell structured nanofibers. As expected, the core-shell 
structured nanofibers had the same surface composition as the nanofibers of pure shell 
polymer. Fig. 4.7 shows the ATR-FTIR spectra of pure PCL nanofibers, BSA/PCL core-
shell fibers with three different inner feed rates, and pure BSA. Fig. 4.8 is the ATR-FTIR 
spectra of pure PGA nanofibers, BSA/PGA core-shell fibers electrospun at three different 
inner flow rates, and pure BSA. As can be seen from both spectra (Fig. 4.7 and 4.8), the 
two typical peaks at the wavelength of 1550 cm-1 (N-H bend, amide II band) and 1650 
cm-1 (C=O stretch, amide I band) for pure BSA were not present in the spectra of either 
BSA/PCL or BSA/PGA core-shell nanofibers. These results suggest that the core 
component BSA was encapsulated inside the shell component PCL and PGA. Similar 
results were also obtained in the ATR-FTIR spectra of FITC-BSA/PCL and FITC-
BSA/PGA core-shell structured nanofibers. 
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Figure 4.7 ATR-FTIR spectra of pure PCL fibers, three types of BSA/PCL core-shell 






Figure 4.8 ATR-FTIR spectra of pure PGA fibers, three types of BSA/PGA core-shell 
structured nanofibers (inner feed rates set at 0.06 ml/hr, 0.10 ml/hr and 0.14 ml/hr), and 
pure BSA.    
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4.3.3 SEM Observation of Degraded BSA/PGA Core-shell Fibers 
Compared with PCL, PGA has much faster degradation rate. This highly crystalline 
polymer will be absorbed in about 4 weeks after implantation and can be completely 
absorbed in 4-6 months [99]. Additionally, after it is fabricated into nanofibers, the 
degradation rate of PGA will be highly enhanced because of the large surface-to-volume 
ratio of nanofiber. Thus within relatively short time period, PGA nanofibers would 
undergo obvious degradation and its inner structure would be revealed.    
Fig. 4.9 shows a comparison between PGA nanofibers and FITC-BSA/PGA core-
shell fibers degraded for 8 days in the presence of HDFs. This degradation induced a 
morphology characterized by a patchy surface with considerable gaps and cracks between 
fragments of both FITC-BSA/PGA core-shell fibers and pure PGA nanofibers (Fig. 4.9, 
A and B). Both nanofiber types experienced extensive rupture after 8-day cell culture 
(Fig. 4.9, C-F). However, FITC-BSA/PGA core-shell fibers showed a completely 
different inner structure from that of pure PGA fibers through a cross-section view (Fig. 
4.9, C-F). Most of the FITC-BSA/PGA core-shell fibers have become hollow tubes (Fig. 
4.9, D and F) after degradation, while the interior of pure PGA fibers remained to be 
intact (Fig. 4.9, C and E). This is easy to understand since after the extensive rupture of 
core-shell fibers, the inner component FITC-BSA would be dissolved in culture medium 
and released out quickly. The remaining shell component would then become a tube 
structure as what we saw in the picture. Although the pure PGA nanofibers also 
experienced the fiber rupture, their interior was still compact PGA. Thus they remained 
to be fibers instead of tubes. Occasionally, few ruptured core-shell fibers with intact 
interior structure were also found in the images of FITC-BSA/PGA core-shell fibers after 
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degradation. This is likely due to the occurrence of discontinuous stream of FITC-BSA 
solution during coaxial electrospinning, which resulted in imperfect encapsulation of 
FITC-BSA and formation of gaps where core component does not exhibit in the core-
shell fibers [34].    
This tubular structure of FITC-BSA/PGA core-shell fibers after degradation also 
demonstrated that we have successfully fabricated the core-shell fibers from fluid that is 
not electrospinnable using coaxial electrospinning.        
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Figure 4.9 SEM images of pure PGA nanofibers (A, C, and E) and FITC-BSA/PGA core-
shell structured nanofibers (B, D, and F) after 8-day cell culture.  (A) Mag. 1000x; (B) 
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4.4 Cell-scaffold Interactions 
Cell morphology and the interactions between HDFs and the core-shell structured 
nanofibers were studied by SEM and laser scanning confocal microscopy.  
 
4.4.1 FITC-BSA/PCL Core-shell Fibers 
In Fig. 4.10, SEM micrographs of the morphology of HDFs cultured on core-shell 
fibers for 14 days are shown. It can be seen that HDFs adhered and proliferated well on 
the core-shell structured nanofibers. Cell-matrix adhesions between HDFs and the core-
shell fibers can be readily observed.  
The expression of cytoskeletal proteins in HDFs as well as the positioning of HDFs in 
the core-shell structured nanofibrous scaffold were studied by fluorescence staining and 
laser scanning confocal microscopy (Fig. 4.11). Apparent expression and accumulation 
of actin filaments inside the HDFs cultured on core-shell fibrous scaffold can be clearly 
observed. More significantly, the cells were found to be able to penetrate the scaffold 
surface and grew beneath the superficial fibers (Fig. 4.11, B, D and F), which suggested 
that the core-shell structured nanofiber mesh might have the capacity to support the cells 
as a 3-D scaffold for cells’ growth and proliferation. Cellular ingrowth phenomenon on 
nanofibrous scaffolds has similarly been reported by others [12,100,101]. Formation of 3-
D cell-scaffold construct is one of the most important requirements for tissue engineering 
scaffolds. Current SEM and confocal results suggest that core-shell nanofibers with the 
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synthetic biodegradable PCL as shell may have played similar roles as those electrospun 
pure PCL nanofibrous scaffolds [50,102]. 
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Figure 4.10 SEM images of HDFs seeded on FITC-BSA/PCL core-shell structured fibers 
with inner flow rates set at 0.06 ml/hr (A-B), 0.10 ml/hr (C-D), and 0.14 ml/hr (E-F) after 














Figure 4.11 Laser scanning confocal microscopy images of HDFs seeded on the FITC-
BSA/PCL core-shell structured fibers with inner feed rates set at 0.06 ml/hr (A-B), 0.10 
ml/hr (C-D), and 0.14 ml/hr (E-F) after 14 days in culture. (A, C, and E) HDFs stained 
with rhodamine-labeled phalloidin (red, for F-actin) and DAPI (blue, for nucleus); (B, D, 
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4.4.2 FITC-BSA/PGA Core-shell Fibers 
Fig. 4.12 shows the morphology of HDFs cultured on core-shell fibers for 8 days 
observed by SEM. As can be seen, HDFs reached almost 100% confluency after 8-day 
culture. They have grown into a flat and compact sheet structure on the core-shell fibers, 
indicating great adhesion and proliferation of HDFs on the core-shell structured 
nanofibers.  
This favorable cell-scaffold interaction suggests that core-shell nanofibers with the 
synthetic biodegradable PGA as shell may have played similar roles as those pure PGA 
tissue scaffolds [103-105].  
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Figure 4.12 SEM images of HDFs seeded on FITC-BSA/PGA core-shell structured fibers 
with inner flow rates set at 0.06 ml/hr (A-B), 0.10 ml/hr (C-D), and 0.14 ml/hr (E-F) after 
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Chapter 5 
Release Kinetics of Core-shell Fibers 
 
5.1 Release Kinetics of BSA/PCL Core-shell Fibers 
Release studies of the BSA/PCL core-shell fibers were performed as described in 
Section 3.8. Total amount of the protein (BSA or FITC-BSA) encapsulated in nanofibers 
was determined by Equation (1)-(3).  
 
5.1.1 Release Study of BSA/PCL Core-shell Fibers in the Absence of Cells 
Release kinetic studies of the BSA/PCL core-shell structured nanofibers in the 
absence of HDFs showed a gradual release of BSA without burst release for more than 
thirty days (Fig. 5.1) This gradual release profile is crucial for regulating cell growth if 
the nanofibrous scaffolds for tissue engineering applications were to encapsulate 
bioactive molecules, or slow passive delivery if the nanofibers were to be used for 
biomolecule delivery applications. The mechanism of this slow release from a core-shell 
type releasing device might involve the following aspects: (1) water permeation through 
the PCL shell and occupation of the PCL matrix; (2) PCL matrix swelling; (3) BSA 
diffusion through the swollen PCL matrix [106].  
 













































Figure 5.1 Percentage release of BSA from 3 different core-shell structured BSA/PCL 
fibers versus time. 
 
 
5.1.2 Release Study of FITC-BSA/PCL Core-shell Fibers Cultured with Cells 
In contrast, faster release of BSA was observed when HDFs were cultured on the 
FITC-BSA/PCL core-shell nanofibers (Fig. 5.2), suggesting that presence of cells has 
potential influences on the release kinetics of the core-shell structured release device. 
This is likely due to the degradative enzymes secreted by the cells, e.g., lysozyme, which 
can catalyze the hydrolysis of polyesters [107]. Such reaction would increase the polymer 
shell degradation rate and potentially accelerate the release of core component. Similar 
degradation results were also reported by Pena et al. [108], who discovered that the 
presence of cells induced a patchy morphology of both alkaline-treated and un-treated 
PCL substrates while those immersed in DMEM for the same time maintained a 
granulated continuous morphology. Bölgen et al. also reported that in vivo degradation of 
electrospun PCL nanofibers was much faster than in in vitro when submerged in Ringer 
solution at pH 7.4 [109].   































































Figure 5.2 Percentage release of FITC-BSA from three different core-shell structured 
FITC-BSA/PCL fibers cultured with HDFs versus time. 
 
 
Furthermore, it was found that fibers electrospun with lower inner feed rate had a 
faster release rate and ultimately less BSA left inside the fibers after the release study. 
This phenomenon is also reflected in the confocal microscopy observations (Fig. 4.11, B, 
D, and F). As can be seen in the confocal images, with the lowest inner feed rate of 0.06 
ml/hr, the fibers emitted the weakest green fluorescence under confocal microscopy (Fig. 
4.11, B), which suggests that it has the lowest amount of FITC-BSA left after 14-day 
release study with HDFs. In contrast, fibers electrospun with higher inner feed rates have 
much stronger green fluorescence corresponding to higher amount of FITC-BSA 
remaining inside the fibers (Fig. 4.11, D and F). This might be explained by the results 
we observed in TEM (Fig. 4.5 and Table 4.3) and SEM (Fig. 4.1, Fig. 4.3, and Table 
4.2). Fibers electrospun with the lowest inner feed rate had the thinnest fiber wall, which 
may allow easy diffusion of BSA out of the shell of the fibers and result in a faster 
release rate. In addition, the lower inner feed rate also led to decreased total fiber 
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diameter and consequently increased the surface-to-volume ratio, which would give rise 
to more efficient and faster BSA release [28]. Therefore, after 14-day release study, the 
thinner fibers had less FITC-BSA left and gave weaker green fluorescence under 
confocal microscopy.  
 
5.2 Release Kinetics of BSA/PGA Core-shell Fibers  
Release studies of the BSA/PGA core-shell fibers were also performed as described in 
Section 3.8. Total amount of the protein (BSA or FITC-BSA) encapsulated in nanofibers 
was determined by Equation (1)-(3).  
 
5.2.1 Release Study of BSA/PGA Core-shell Fibers in the Absence of Cells 
Similarly, gradual release of BSA without burst release was observed in release 
kinetic studies of the BSA/PGA core-shell structured nanofibers in the absence of HDFs 
(Fig. 5.3). And fibers electrospun with lower inner feed rate had a faster release rate of 
BSA. But significantly different from BSA/PCL core-shell fibers, after Day 4, there were 
sharp increases of BSA from all the three BSA/PGA core-shell fibers electrospun at 
different inner flow rates. This might be explained by the observations that after 
suspended in PBS and shaken at 37°C for 4 days, BSA/PGA core-shell fibers started to 
degrade. As seen in Fig. 4.9, degradation of BSA/PGA core-shell fibers resulted in 
extensive fiber ruptures, instead of forming tiny holes on the wall of fibers. Therefore, 
besides diffusion through the PGA walls, a lot of BSA was washed away from the cross-
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section of the core-shell fibers quickly after their fracture. Thus a sharp increase of BSA 
release was observed in the release profile of BSA/PGA core-shell fibers after 4 days. As 
the dispersion time increased, BSA/PGA core-shell fibers underwent continuous 
degradation and ruptures. Thus the high speed BSA release continued, but the increasing 





















































Figure 5.3 Percentage release of BSA from 3 different core-shell structured BSA/PGA 
fibers versus time. 
 
 
The mechanism of release from this core-shell type releasing device is more complex 
than that of the BSA/PCL type. It might involve the following aspects: (1) water 
permeation through the PGA shell and occupation of the PGA matrix; (2) PGA matrix 
swelling; (3) BSA diffusion through a tortuous, water-filled path in the swollen PGA 
matrix; (4) PGA degradation; (5) bulk BSA release from the ruptured sites of degraded 
PGA matrix [106].  
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5.2.2 Release Study of FITC-BSA/PGA Core-shell Fibers Cultured with Cells 
Similarly, faster release of BSA was observed when HDFs were cultured on the 
FITC-BSA/PGA core-shell fibers (Fig. 5.4), which demonstrated further that the 
presence of cells has potential influences on the release kinetics of the core-shell 
structured release device. And consistent with the release profiles of BSA/PGA core-shell 
fibers in the absence of cells, fibers electrospun with the slowest inner feed rate had the 




























































Figure 5.4 Percentage release of FITC-BSA from three different core-shell structured 
FITC-BSA/PGA fibers cultured with HDFs versus time. 
 
 
In summary, to establish a novel biomolecule release model, we encapsulated BSA 
into our core-shell fibrous scaffolds and studied the influences of various factors like 
electrospinning feed rate and cell growth on its release behaviors. As a versatile tissue 
engineering scaffold which also incorporates controlled delivery system, different 
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combinations of the core and shell components can be used in coaxial electrospinning to 
obtain various core-shell structured nanofibers for different requirement of release and 
cell growth. For example, we can choose the core component from numerous growth 
factors, enzymes, bioactive molecules, or drugs, based on our desired release targets. 
Similarly, shell component can be selected from a variety of biodegradable polymers 
with different biodegradabilities, such as poly(caprolactone) (PCL), poly(L-lactic acid) 
(PLLA), poly(L-lactide-co-ε-caprolactone) [P(LLA-CL)], poly(lactic-co-glycolic acid) 
(PLGA), and poly(glycolic acid) (PGA), to generate different release profiles.  
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Chapter 6 
Biological Activity Protection of Core-shell Fibrous 
Scaffold 
 
6.1 Preliminary Experiments on Compatibility of Materials 
In the previous study, two protein-encapsulating core-shell fibrous scaffolds with 
different biodegradabilities were successfully fabricated through coaxial electrospinning. 
They were characterized for their morphology, core-shell structure and release behaviors 
respectively. But how the encapsulated component would affect the cellular behavior and 
whether the core component’s integrity could be maintained after the fabrication process 
were still unclear.  
To investigate the biological activity protection of the core-shell fibrous scaffold, 
human coronary artery endothelial cells (HCAECs) and the growth factor that 
specifically stimulates proliferation of HCAECs, human vascular endothelial growth 
factor (VEGF), were selected as the biological system to test our scaffold.  
 
6.1.1 Attachment and Proliferation of HCAECs on Different Polymers 
The best investigated polymers for the manufacturing of scaffolds are the polyesters, 
i.e., poly(caprolactone) (PCL), poly(L-lactic acid) (PLLA), poly(L-lactide-co-ε-
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caprolactone) [P(LLA-CL)], poly(lactic-co-glycolic acid) (PLGA), and poly(glycolic acid) 
(PGA). However, the application of such polymers in blood vessel tissue engineering 
may be limited by some unfavorable material properties. For example, their 
hydrophobicity could lead to unwanted non-specific adsorption of proteins from 
biological fluids and subsequent low endothelial cell attachment [110]. Evidence have 
been shown that human endothelial cells would have poor attachment and viability if 
cultured on highly hydrophobic biosynthetic polymers PCL [93,110], PLLA [111,112], 
and their copolymer P(LLA-CL) [23,113]. Therefore, preliminary experiments on 
compatibilities of PLGA and PGA to HCAECs were performed, in order to determine the 
suitable shell material for this biological system.   
Fig. 6.1 shows the morphology of HCAECs cultured on PGA (A-C) and PLGA (D) 
nanofibers for 3 days observed by SEM. As can be clearly seen, HCAECs attached well 
on the PGA nanofibrous surface and reached almost 100% confluency after only 3-day 
culture. They have formed a flat layer of cells spreading smoothly on the surface of PGA 
nanofibers. Favorable cell-cell and cell-fiber interactions were easily observed (Fig. 6.1, 
C). In contrast, much fewer HCAECs were found to be still alive or in good condition 
after cultured on PLGA nanofibers for 3 days (Fig. 6.1, D). Instead of forming a compact 
cell layer and establishing interactive cell-cell contact, HCAECs were separated from 
each other and shrinking on the PLGA nanofibrous surface. Many cells were found 
already dead.  
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Figure 6.1 SEM images of HCAECs seeded on PGA (A-C) and PLGA (D) nanofibers 
after 3 days in culture. (A) Mag. 150x; (B) Mag. 600x; (C) Mag. 2500x; (D) Mag. 500x. 
 
 
Therefore, PGA was chosen as the shell material to encapsulate VEGF. HCAECs 
were cultured on the VEGF/PGA core-shell fibers to investigate the biological activity 
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6.1.2 Functional Marker Expression of HCAECs 
In addition, functional marker expressions of HCAECs cultured on PGA nanofibers 
was also performed to verify the biocompatibility of PGA.  
Platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) is a universal EC 
marker, whose expression can represent the differentiation status of endothelial cells. 
Therefore, this surface adhesion protein characteristically expressed by ECs was studied 
using immunofluorescent staining and confocal microscopy. Fig. 6.2 shows the confocal 
images of immuno-stained HCAECs cultured on PGA nanofibers. As can be seen, these 
HCAECs gave normal CD-31 expression patterns (Fig. 6.2, A) [23].  
The expression of extracellular adhesion molecule fibronectin by HCAECs cultured 
on PGA nanofibers was also investigated (Fig. 6.2, B). Fibronectin serves as a linker in 
the ECM and sometimes functions as a general cell adhesion molecule by anchoring cells 
to collagen or proteoglycan substrates. FN also can organize cellular interaction with the 
ECM by binding to different components of the extracellular matrix and to membrane-
bound FN receptors on cell surfaces. In the immunostaining results shown below, 
apparent expression and accumulation of FN inside and around HCAECs can be clearly 
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Figure 6.2 Laser scanning confocal microscopy images of HCAECs seeded on PGA 
nanofibers stained with functional markers CD31 (A) and FN (B) after 3 days in culture. 
Nucleus were stained with PI.     
 
 
These results indicated preservation of HCAECs’ characteristic phenotypes on PGA 
nanofibrous scaffold.  
 
6.2 Fabrication and Characterizations of VEGF/PGA Core-shell Fibers 
 
6.2.1 Optimizations of Coaxial Electrospinning Parameters 
The processing parameters used to fabricate VEGF/PGA core-shell fibers with our 
coaxial electrospinning setup were listed in Table 6.1. As optimized in previous study of 
BSA/PGA core-shell fiber fabrication (Section 4.1), when the concentration of shell 
component PGA in HFIP was 10% (w/v) and the feed rate was set at 2 ml/hr, stable and 
A B 
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continuous production of uniform PGA nanofibers without beads could be easily 
achieved in relatively broad ranges of voltage (>8.8 kV) and distance (>10cm). 
Moreover, with these settings, protein-encapsulating PGA core-shell fibers were 
successfully fabricated through our coaxial electrospinning setup. Therefore, 10% (w/v) 
PGA in HFIP was used as the shell component for fabrication of VEGF/PGA core-shell 
fibers and its feed rate was set at a constant of 2 ml/hr, as can be seen from Table 6.1.  
 
Table 6.1 Coaxial electrospinning parameters for VEGF/PGA core-shell structured 
nanofibers. 



















VEGF/PGA 10 µg/ml 0.1 g/ml 11.5 0.14 2 16 21.4 67 
 
 
Similar with the BSA solution used in previous release studies, VEGF was also 
dissolved in PBS which can provide a neutral buffer environment to protect the growth 
factor. Furthermore, the addition of charged ions to the core solution by PBS could 
possibly help the formation of uniform nanofibers with minimal or no beads-on-string 
structure [114]. 10 µg/ml of VEGF in PBS was used as the core component for coaxial 
electrospinning (Table 6.1). Based on previous release study results (Section 5.2.2), 
when cultured with cells, FITC-BSA/PGA core-shell fibers with inner feed rate at 0.14 
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ml/hr had the fastest release rate. This fast release rate is crucial for HCAECs after 
seeding on the scaffold in the first several hours. Fast local release of VEGF is essential 
for HCAECs’ initial attachment, viability maintenance, and subsequent proliferation, 
especially when they will be cultured in basal medium where only very low concentration 
of serum is present and no growth factor is supplemented. Therefore, 0.14 ml/hr was 
chosen as the inner feed rate for VEGF/PGA core-shell fiber fabrication, to obtain fibers 
with highest VEGF release rate while stable jet formation and continuous core-shell fiber 
production can still be maintained (Table 6.1).   
As discussed in previous sections, the protruding distance of the inner capillary tube 
below the outer capillary tube (Fig. 3.1) was also important for stable compound jet 
formation. It was carefully adjusted until a stable compound jet could be observed at the 
exit the capillary tube.  
Voltage and distance were also adjusted accordingly when the inner feed rate was set 
at 0.14 ml/hr, to obtain suitable field intensity for stable and continuous core-shell fiber 
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6.2.2 Morphology and Size Distribution of VEGF/PGA Fibers 
Consistent with previous findings, uniform ultrafine fibers were successfully 
fabricated under stable processing conditions, i.e., no dripping of droplets, formation of a 
stable compound Taylor cone at the exit of the capillary tube, and continuous jet ejection 
during coaxial electrospinning. Although the core component VEGF solution was either 
not electrospinnable, it had little influence on the formation of resultant core-shell fibers. 
As can be seen in the SEM images (Fig. 6.3), randomly oriented, bead-free, and highly 
porous nanofiber mats were produced with the optimized coaxial electrospinning 
conditions (Table 6.1).  
 
  
Figure 6.3 SEM images of VEGF/PGA core-shell structured nanofibers. The inner flow 
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The size distribution result is shown below (Fig. 6.4). The averaged fiber diameter of 





































Figure 6.4 Size distribution of the VEGF/PGA core-shell structured nanofibers. The inner 
feed rate was set at 0.14 ml/hr when performing coaxial electrospinning. 
 
 
6.2.3 TEM Observation of the Core-shell Structure 
The core-shell structure of the nanofibers was examined by TEM. Representative 
TEM image of VEGF/PGA core-shell fibers is shown in Fig. 6.5. Sharp boundaries of 
core (VEGF) and shell (PGA) components could be clearly observed.  
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Figure 6.5 Representative TEM images of VEGF/PGA core-shell structured nanofibers. 




Occasionally, we also found that there were cases where the inner component 
extended to the edge of the nanofiber (Fig. 6.5, arrow). This phenomenon might be 
attributed to the flow instability of the inner component and the bending instability during 
the coaxial electrospinning process [45,94].  
 
6.3 Proliferation Stimulation of VEGF/PGA Core-shell Fibers on 
HCAECs 
The bioactivity of the electrospun VEGF was analyzed by observing the proliferation 
stimulation effect of VEGF/PGA core-shell fibers on HCAECs. Proliferation of HCAECs 
on TCPs, PGA nanofibers, and VEGF/PGA core-shell fibers was measured by cell 
counting using SEM images. Cells were cultured in starvation medium where no external 
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growth factor was added and only 1% fetal bovine serum was supplemented. Cell number 
was counted 2-, 4-, and 6-day post-seeding.  
HCAECs proliferation results on TCPs, PGA nanofibers, and VEGF/PGA core-shell 
fibers are shown in Fig. 6.6. Morphology of HCAECs cultured on different substrates is 








































Figure 6.6 Proliferation results of HCAECs on TCPs, PGA nanofibers, and VEGF/PGA 
core-shell nanofibers in starvation medium (EC basal medium without any growth factor, 
1% fetal bovine serum, and antibiotics). Cell number was counted 2-, 4-, and 6-day post-
seeding. The values are means of cell count obtained from three wells for each treatment.  
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Since HCAECs were seeded in starvation medium and no more fresh medium was 
supplemented throughout the experiment, initial cell attachment and subsequent 
proliferation of HCAECs might be affected. This might explain the decreasing in cell 
number over time for all three different substrates, TCPs, VEGF/PGA core-shell fibers, 
and PGA fibers (Fig. 6.6).   
However, the encapsulation of VEGF into PGA nanofibers increased HCAECs 
proliferation with an induction of 91%, 119%, and 329% on day 2, 4, and 6, respectively, 
as compared with the cell proliferation results on pure PGA nanofibers (Fig. 6.6). Cell 
morphology observation was also consistent with this result. Much less cells were found 
attached to the PGA nanofibrous scaffold than cells on the VEGF/PGA core-shell fibers 
after 2-day culture in starvation medium (Fig. 6.7, A-D). Moreover, instead of fully 
spreading on the nanofibrous surface, many of the cells on PGA fibers showed a rounded 
shape and were separated from each other (Fig. 6.7, B), whereas cells grown on 
VEGF/PGA core-shell fibers spread out and formed tight cell-cell contact (Fig. 6.7, D). 
The morphology and cell-cell interaction characteristics of the latter are important for 
potential applications in engineering blood vessel scaffolds. An EC monolayer with tight 
cell-cell contacts covering the whole foreign material surface may prevent the 
development of intimal hyperplasia. Through this tight layer of ECs, thrombosis and 
immunoreactions caused by direct contact between the blood and the foreign material can 
be avoided.     
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Figure 6.7 SEM images of HCAECs cultured with 1% FBS media for 2 days on PGA 
nanofibers (A and B), VEGF/PGA core-shell fibers (C and D), and TCPs (E). (A) Mag. 
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However, TCPs still had the highest cell number among these three different 
substrates (Fig. 6.6 and Fig. 6.7). Compared to TCPs, the decrease of HCAECs 
proliferation on VEGF/PGA core-shell fibers might be attributed to the abrupt release of 
acidic PGA degradation products [115,116]. Nonetheless, this experiment did indicate 
that the VEGF released from the VEGF/PGA core-shell fibers retained its bioactivity for 
proliferation stimulation of HCAECs for at least 6 days. Such a sustained release of 
bioactive VEGF would be useful for drug delivery applications, as VEGF is known to 
have a short half-life in vivo [117,118]. For example, in mouse circulation, VEGF 
disappeared with a half-life of around 8 min and complete clearance by 30 min [118]. 
 
6.4 Functional Marker Expression of HCAECs Grown on VEGF/PGA 
Core-shell Fibers 
The expression of PECAM-1 (CD31) in HCAECs cultured on TCPs, PGA nanofibers, 
and VEGF/PGA core-shell fiber was studied using immunofluorescent staining and 
confocal microscopy. PECAM-1 (CD31) is one surface adhesion protein 
characteristically expressed on cell membranes of blood vessel endothelial cells. 
PECAM-1 expression occurs on the EC membrane close to intercellular junctions and 
regulates EC-EC adhesion and EC-leukocyte adhesion. The increased expression of 
PECAM-1 is usually believed to favor the endothelialization [119], whereas decreased 
expression of PECAM-1 is believed to be a sign of EC damages [120].  
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Fig. 6.8 shows confocal images of immunostained HCAECs cultured on three 
different substrates after 2 days. All these images were taken under exactly the same 
settings and parameters. As compared to cells on TCPs and pure PGA fibers, HCAECs 
cultured on VEGF/PGA core-shell fibers showed stronger staining of PECAM-1 per cell. 
This might be attributed to the absence of growth factor for cells on TCPs and PGA fibers. 
Growth factors supplemented in the culture medium are usually important for cell 
viability, proliferation, and function maintenance.   





Figure 6.8 Immunofluorescence staining of PECAM-1 in HCAECs cultured with 1% 
FBS culture media for 2 days on TCPs (A-B), PGA fibers (C-D), and VEGF/PGA core-
shell fibers (E-F). B, D, and F are images of higher magnification. Nucleus were stained 
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Therefore it is not surprising that HCAECs on pure PGA fibers had lower PECAM-1 
expression than those on core-shell fibers (Fig. 6.8, C-F). Lack of growth factor resulted 
in fewer cell surviving on the PGA nanofibers after 2-day culture in starvation medium. 
This low cell density made interactions with surrounding live cells very difficult, which 
can be also observed in SEM images (Fig. 6.7, A-D). Thus strong PECAM-1 expression 
at cell-cell contact was seldom seen in cells on PGA nanofibers.  
Although more cells attached to the TCPs after 2 days, progressive starvation of 
growth factor could still cause cell function damages, which might lead to the lower 
expression of PECAM-1 in cells on TCPs than those on core-shell fibers (Fig, 6.8, A, B, 
E, and F).  
Strong expression of functional marker PECAM-1 in cells cultured on VEGF/PGA 
core-shell fibers indicated that the novel core-shell nanofibrous biomaterial could 
successfully maintain the phenotype of HCAECs by releasing growth factor VEGF while 
maintaining its bioactivity. This capability of cell phenotype maintenance is crucial for 
in-vivo tissue engineering applications. 





Results from this work demonstrated the possibility of using coaxial electrospinning 
to fabricate nanofibrous tissue scaffold with innate controlled biomolecule delivery 
system.  
Model protein BSA was successfully encapsulated inside PCL and PGA nanofibers in 
a core-shell structure through coaxial electrospinning. Alternation of the inner feed rate 
was found to influence the fiber diameter, PCL shell thickness, and BSA release rate. 
Release kinetic studies of BSA/PCL and BSA/PGA core-shell fibers in the absence of 
HDFs indicated that the core-shell structure could deliver BSA continuously over thirty 
and ten days, respectively, instead of an initial burst release. The BSA release rate was 
increased with cells’ grown on these fibers. This release profile is critical for regulating 
cell growth in tissue engineering applications in which bioactive molecules need to be 
encapsulated and sustained passive delivery is preferred.  
Furthermore, proliferation studies of HCAECs seeded on VEGF/PGA core-shell 
fibers indicated that VEGF released from VEGF/PGA core-shell fibers retained its 
bioactivity for proliferation stimulation of HCAECs for at least 6 days.  
This study suggests that the core-shell structured nanofibers could possibly have great 
potentials as a novel controlled drug delivery system, as well as a tissue engineering 
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scaffold encapsulating growth factors, enzymes, bioactive molecules, drugs, and even 
antibiotics for tissue repair and regeneration.    
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